Hospice Fraud Statistics: The Patients Behind the Percentages

Whistleblower Justice Network

Hospice fraud statistics show the money at stake when Medicare pays for every enrolled day, including days when no one visits. For a nurse seeing patients kept on service, a biller watching repeated admissions, or a competitor losing referrals, the useful question is what happened to the patients behind the percentage. Hospice fraud becomes concrete when the clinical record, the bill, and management’s instructions tell different stories.

The Average Hospice Stay Hides the Longest Stays

The average hospice stay is much longer than the middle patient’s stay. The Medicare Payment Advisory Commission’s July 2026 Data Book puts the median lifetime stay among Medicare hospice patients who died in 2024 at 19 days. The mean was 99.6 days, and the 90th percentile was 291 days. The long end pulls the average upward.

Lifetime care can span more than one enrollment. The commission’s follow-up found patients returning to hospice after discharge, so a completed episode can be only part of a patient’s stay.

Diagnosis and setting change the comparison too. In the commission’s figures, the average lifetime stay was 51 days for cancer and 169 days for neurological conditions. The median was 26 days at home and 63 days in assisted living. Patient mix changes what the company average means.

Costs tend to be highest around admission and death and lower in between. Keeping someone enrolled can keep the daily payment coming while the work falls.

Why Long Stays Matter to Hospice Payments

Long stays account for a large share of Medicare hospice spending. The commission reported that $17.5 billion in calendar 2024 went to beneficiaries whose lifetime stays exceeded 180 days, just over 60% of hospice spending. The financial incentive sits in those accumulated days.

Hospice eligibility turns on a prognosis of six months or less if the illness runs its normal course. The benefit provides two periods of up to 90 days, followed by renewable periods of up to 60 days while the patient remains eligible. The clinical question returns at recertification: what supports the prognosis now?

The setting can make the payment especially attractive. In its study of hospice care in assisted living facilities, the HHS Office of Inspector General examined all Medicare hospice claims from 2007 through 2012. It found longer stays and higher payments in assisted living than in other settings, with typically fewer than five hours of visits per week for beneficiaries receiving routine home care there. The report identified an incentive to seek patients with longer stays and less complex care needs.

Live Discharge Rates Depend on Whom You Compare

Live discharge rates change with the patients and providers being compared. In the Medicare Payment Advisory Commission’s analysis of hospice episodes in 2010, the rate was 36% at hospices above Medicare’s annual payment cap and 16% at those below it. The cap limits a provider’s annual payments according to its beneficiary count, making patient mix financially consequential.

The Government Accountability Office’s 2026 report on routine home care payments compared a different population: selected beneficiaries at hospices grouped by visit frequency. In its 2024 analysis, 31% of beneficiaries at low-visit hospices left alive, compared with 14% at high-visit hospices. The combination of fewer visits and more live discharges directs attention to what care the patients received and why their enrollment ended.

The extreme end of the distribution deserves attention of its own. In its fiscal 2027 payment rule, the Centers for Medicare & Medicaid Services reported more than 400 hospices with live-discharge rates from 90 to 100% in fiscal 2025. The agency said it was unclear how much reflected beneficiary choice and how much reflected inappropriate enrollment. That unresolved explanation is exactly where an insider’s knowledge becomes useful: what did patients choose, what did clinicians conclude, and what did management direct?

The discharge reason matters. The recorded event can reflect a transfer, a patient revoking the benefit, or a provider ending care. A rate alone loses that distinction. For someone inside the hospice, the explanation lies in the patient’s election, the clinical assessment, the discharge date, and the instructions staff received.

Early and Late Live Discharge in the Hospice Care Index

An early or late live discharge HCI measure tracks when a hospice patient leaves alive as part of the Hospice Care Index quality score. The 2026 working paper Quality, Reputation, and Reimbursement Design in the Hospice Industry, from Kansas State University, describes its ten indicators, including gaps in nursing visits, early and late discharge, and hospitalization following discharge. The total score combines different care practices; an individual indicator can reveal which part of patient care needs attention.

For-Profit Hospices Have a Smaller Share of Patients Than Providers

For-profit hospices made up about 82% of Medicare hospice providers in 2024 but served 60% of the patients, according to MedPAC’s March 2026 report. Nonprofit hospices are larger on average.

The Medicare Payment Advisory Commission counted 6,706 providers with a paid hospice claim that year, up from 2,255 in 2000 in its March 2013 report. A provider number can cover more than one operating location.

State licensing counts tell another part of the story. The California State Auditor’s agency-growth table counted 1,841 hospice agencies in Los Angeles County in 2021. That counts licensed agencies, rather than patients receiving care.

What Ownership Explains, and What the Comparisons Show

For-profit ownership is associated with longer stays and higher live discharge in several studies. The Government Accountability Office’s 2019 report found that 22.1% of beneficiaries served by for-profit hospices in 2017 were discharged alive, against 12.0% at nonprofits.

Milliman’s Hospice Medicare Margins, published in 2019 and commissioned by the National Partnership for Hospice Innovation, examined Medicare claims and hospice cost reports. Its fiscal 2017 findings show that diagnosis alone did not remove the difference:

For-profit hospices had longer median lengths of stay than nonprofit hospices for all diagnosis categories.

Hospice Medicare Margins, Milliman, 2019

The same analysis found different staffing patterns: nonprofit hospices supplied more nursing and social worker visits per patient day, while for-profit hospices supplied more aide visits. A total visit count can hide which professional actually saw the patient.

Milliman also found that higher live-discharge rates were associated with higher Medicare margins before accounting for other patient and hospice characteristics. After those characteristics entered the model, the association reversed. A dashboard showing only discharge rates and profit misses that patient mix.

Other government comparisons complicate the ownership story. In the HHS Office of Inspector General’s 2019 report on hospice deficiencies, for-profits represented 67% of poor performers and 64% of all Medicare hospices. The inspector general described those distributions as similar.

The Government Accountability Office’s selected 2024 visit groups ran in the opposite direction from a simple low-care, for-profit explanation. For-profit hospices served 78% of beneficiaries in the highest-visit group and 67% in the lowest-visit group. Ownership gives an investigator a comparison to examine. The visit records explain what the provider delivered.

How Much Did Hospice Fraud Cost in 2023?

The audits discussed here give no national hospice fraud loss total for 2023. They do show how much Medicare paid for care that failed eligibility requirements, and how much the daily payment system can pay for limited visits.

Medicare hospice spending gives the scale of this part of health care: the Medicare Payment Advisory Commission reported $28.3 billion for calendar 2024, while the Government Accountability Office reported $27.5 billion for fiscal 2024.

What GAO’s Low-Visit Hospice Savings Estimate Measures

GAO’s low-visit hospice savings estimate compares actual hospice payments with what comparable services would cost under home health per-visit rates.

In the selected 2024 groups, low-visit hospices averaged 2.5 visits per beneficiary each week, against 5.5 at high-visit hospices. Across the selected claims from 2022 through 2024, Medicare paid $16.7 billion for routine home care. The Government Accountability Office estimated that comparable services would have cost $9.1 billion under home health per-visit rates, a $7.6 billion modeled difference.

Substantially different visit schedules can receive the same daily rate.

The OIG New-Enrollee Audit Measures a Selected Risk

The HHS Office of Inspector General’s June 2026 new-enrollee audit projected $255.1 million in potential savings for a selected group receiving care in fiscal 2021. The group consisted of new hospice enrollees without inpatient or emergency-room claims in the preceding 18 months.

The inspector general reviewed 100 initial certification periods. Documentation for 45 failed Medicare requirements: clinical information did not support terminal illness in 21, while 24 failed eligibility documentation requirements.

The Records Behind a Statistical Pattern

Hospice billing fraud allegations against Good Shepherd Hospice of Mid America included an executive director’s review of 79 active patient files. According to the whistleblowers’ complaint, as many as 30 lacked enough medical documentation to support eligibility at admission.

The complaint also attributed this instruction to a regional nurse:

everyone who comes onto hospice as ‘terminal’ will always be ‘terminal.’ They were admitted as ‘terminal’ and they will always be ‘terminal,’ so just get that through your heads.

Alleged instruction quoted in the whistleblowers’ complaint, United States ex rel. Cordingley and Jones v. Good Shepherd Hospice, Mid America, Inc.

The alleged instruction supplies what the count cannot: a management position about keeping patients enrolled regardless of later clinical evidence.

The same complaint alleged that management removed the no-longer-eligible option from a discharge dropdown menu. The people deciding which choices staff can record can also change what a later report appears to show.

A separate complaint against HPC Healthcare alleged that staff had to keep ineligible patients enrolled through the recertification period to capture the full billing cycle, then described a program for quickly readmitting patients who had not been recertified. The complaint’s account of those instructions connects duration, discharge, and renewed billing. An enrollment report can show repeated episodes. The person who heard the instructions can explain why they occurred.

A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers. The opportunity rests on the conduct and payments the insider can explain, not on a national estimate of healthcare fraud.

You Know What the Dashboard Leaves Out

If your stay reports, discharge records, or patient files tell a story management keeps dismissing, speak to one of our whistleblower experts about the hospice you know. We connect the numbers to the clinical decisions and Medicare claims to build your strongest hospice whistleblower case with hospice fraud whistleblower lawyers who know eligibility and discharge cases. We stay beside you through the process.

WHISTLEBLOWER JUSTICE NETWORK CAN HELP YOU
Make a difference.
Whistleblower Justice NetworkReport Fraud
100% CONFIDENTIALFREE CONSULTATION24 / 7 / 365